Sensotrend Pitch for SeedForum
of 16
/16
-
Upload
mikael-rinnetmaeki -
Category
Healthcare
-
view
239 -
download
11
Embed Size (px)
description
Presenting Sensotrend in SeedForum pitch event. Some progress from the working copy (http://www.slideshare.net/mikaelrinnetmaki/sensotrend-pitch-for-seedforum-draft). Strictest enforcement of the pitch structure that we've experienced so far. Feedback from audience indicated this is both good (easier to compare startups) and bad (gets boring quite soon).
Transcript of Sensotrend Pitch for SeedForum
AUTOMATED DIABETES DIARY
Visualizing data fromwellness trackers and medical devicesfor personalized diabetes treatment
TRACKAND
LEARN
Diabetes treatment costs in 2013: $ 548 B
$
†<60y
> 1 000 apps, only 1.2 % penetration
“Apps rely on manual input of data.”“No interoperability with glucometers, health & fitness apps.”
Glucose readings from meter & pumpActivity, nutrition info from trackersAnnotations
Support for multiple metersPatient owns the data
Competition
PHR
Meals ActivityStress
Business model: Phase 1
Go-to-market via• Diabetes organizations• Healthcare organizations• App stores
People with diabetes pay 79 € / y
Revenue Streams: Phase 2Healthcare organizations pay for service and data– Patient empowerment saves cost– Personalized healthcare improves results– Legal obligations
Pharma companies pay for data– Valuable for product development
Insurance companies pay for data– Improved risk calculation– Payer role, want to improve treatment
Device manufacturers pay for integration– Better value for users
H2/13 2014 2015 2016 2017 2018 2019
Personnel 3 3 3 5 8 12 16 20 30 60 75 90
Users 2 2 500 2.5 K 15 K 40 K 70 K 250 K 600 K 1.2 M 2.5 M 6 M
Revenue 0 0 675 K 1.5 M 11.4 M 92 M 484 M
Cost 0 195 K 950 K 1.4 M 16.1 M 52 M 120 M
Ebitda 0 -195 K -275 K 100 K -4.7 M 40 M 364 M
First users,
soft launch
Launch: F
inland
Launch: E
urope
Medical D
evice Cert.
Financials and Roadmap
FDA ap
proval
Launch
: USA
& Canad
a
Pirjo Ilanne-Parikka, MD, Finnish Diabetes Assoc.Jorma Lahtela, MD, UTA / UKU / TAYSPäivi Hannula, MD, PSHPAntti Virkamäki, MD, CMO, MendorAtte Vadén, MD, Koskiklinikka / MediverkkoJyrki Lähde, MD, Terveystalo
Type 1 diabetic (14 y), software pro (15 y)Startup experience (14 y)
Type 1 diabetic (4 y), software pro (15 y)Military software, visualisation
Healthcare PR, marketing (6 y)Protomo startup coaching
Mikael
Timo
Assi
Advisors
Trade Sale Opportunities
Investment Opportunity
Looking for 100 000 €, to– finalize product, start user trials in Q2 2014– launch in Finland on World Diabetes Day 14.11.2014– prepare for next round in Q1 2015, for medical device
certification and international growth
Also looking for advice and connections
…making sense of diabetes trends
Mikael Rinnetmä[email protected]
+358 50 3855511linkedin.com/in/mikaelrinnetmaki
twitter.com/mrinnetmaki
www.sensotrend.com/linkedin.com/company/sensotrendtwitter.com/sensotrendfacebook.com/sensotrend gust.com/c/sensotrend
Power Pitch
• Sensotrend makes life with diabetes easierwith an automated diabetes diaryutilizing data from wellness trackers.
• Our team consists of diabetics and their relatives, and we’ve got 6 top name diabetes doctors as advisors.
• We have a scalable business model with multiple revenue streams, and a first mover advantage on a globally growing market, driven by changes in legislation.
![Untitled-3 [content.alfred.com] · 2017-10-03 · LESSON I Pitch 2 Pitch 3 Pitch 4 Pitch 5 Pitch 6 Pitch 7 Pitch 8 Pitch 10 Pit h 11 Pitch 12 Pitch 13 Pitch 14 Pitch 15 Pitch 16 Pitch](https://static.fdocuments.net/doc/165x107/5f1f182654507e355339a7ee/untitled-3-2017-10-03-lesson-i-pitch-2-pitch-3-pitch-4-pitch-5-pitch-6-pitch.jpg?t=1701931926)
